TABLE 3

Fraction of Response Days in Relation to Total Number of Days After Therapy

Posttherapy periodTreatment groupP
186Re-etidronate (n = 43)Placebo (n = 36)
0–42 d (6 wk)28.8 ± 5.015.7 ± 4.20.026
0–84 d (12 wk)26.8 ± 5.112.9 ± 3.50.028
  • Data are mean percentage ± SD.